BR0012500B1 - vacina inativa contra a calicivirose felina. - Google Patents

vacina inativa contra a calicivirose felina.

Info

Publication number
BR0012500B1
BR0012500B1 BRPI0012500-8A BR0012500A BR0012500B1 BR 0012500 B1 BR0012500 B1 BR 0012500B1 BR 0012500 A BR0012500 A BR 0012500A BR 0012500 B1 BR0012500 B1 BR 0012500B1
Authority
BR
Brazil
Prior art keywords
vaccine against
against feline
inactive vaccine
feline calicivirosis
calicivirosis
Prior art date
Application number
BRPI0012500-8A
Other languages
English (en)
Other versions
BR0012500A (pt
Inventor
Herve Poulet
Sylvain Gabriel Goutebroze
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9909420A external-priority patent/FR2796281B1/fr
Application filed filed Critical
Publication of BR0012500A publication Critical patent/BR0012500A/pt
Publication of BR0012500B1 publication Critical patent/BR0012500B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/125Picornaviridae, e.g. calicivirus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1009Picornaviridae, e.g. hepatitis A virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/16011Caliciviridae
    • C12N2770/16034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/16011Caliciviridae
    • C12N2770/16061Methods of inactivation or attenuation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/16011Caliciviridae
    • C12N2770/16061Methods of inactivation or attenuation
    • C12N2770/16063Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BRPI0012500-8A 1999-07-16 2000-07-13 vacina inativa contra a calicivirose felina. BR0012500B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9909420A FR2796281B1 (fr) 1999-07-16 1999-07-16 Vaccin inactive contre la calicivirose feline
FR0001759A FR2796282B1 (fr) 1999-07-16 2000-02-11 Vaccin inactive contre la calicivirose feline
PCT/FR2000/002050 WO2001005835A1 (fr) 1999-07-16 2000-07-13 Vaccin inactive contre la calicivirose feline

Publications (2)

Publication Number Publication Date
BR0012500A BR0012500A (pt) 2002-04-02
BR0012500B1 true BR0012500B1 (pt) 2011-03-22

Family

ID=26212168

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0012500-8A BR0012500B1 (pt) 1999-07-16 2000-07-13 vacina inativa contra a calicivirose felina.

Country Status (17)

Country Link
EP (1) EP1194450B1 (pt)
JP (1) JP4841775B2 (pt)
KR (3) KR100934687B1 (pt)
AR (1) AR024770A1 (pt)
AT (1) ATE280182T1 (pt)
AU (1) AU6576400A (pt)
BR (1) BR0012500B1 (pt)
CA (1) CA2378802C (pt)
DE (1) DE60015127T2 (pt)
DK (1) DK1194450T3 (pt)
ES (1) ES2231233T3 (pt)
FR (1) FR2796282B1 (pt)
HU (1) HU228430B1 (pt)
MX (1) MXPA02000536A (pt)
PL (1) PL205298B1 (pt)
PT (1) PT1194450E (pt)
WO (1) WO2001005835A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7850978B2 (en) * 1999-07-16 2010-12-14 Merial Limited Vaccine against feline calicivirus
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
ATE526034T1 (de) * 2004-01-21 2011-10-15 Merial Ltd Verbesserte inaktivierte fcv-vakzinen
DE602006019878D1 (de) * 2005-07-28 2011-03-10 Pfizer Prod Inc Impfstoff gegen felines calicivirus (fcv), der ein fcv kapsid protein oder ein isoliertes fcv kapsid protein mit der protein sequenz seq id no: 13 oder mit einer protein sequenz, die zumindestens zu 95% identisch zur seq id no: 13 ist enthält.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991001332A1 (en) * 1989-07-21 1991-02-07 The Upjohn Company Feline calicivirus capsid protein and nucleotide sequence
JP3514482B2 (ja) * 1992-02-28 2004-03-31 財団法人化学及血清療法研究所 抗ネコカリシウイルス組換え抗体および該抗体からなる治療剤
US6231863B1 (en) * 1997-06-10 2001-05-15 American Cyanamid Company DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same

Also Published As

Publication number Publication date
KR100859824B1 (ko) 2008-09-23
KR20020020785A (ko) 2002-03-15
KR100934687B1 (ko) 2009-12-31
MXPA02000536A (es) 2002-07-30
EP1194450B1 (fr) 2004-10-20
DK1194450T3 (da) 2005-02-21
PL205298B1 (pl) 2010-04-30
EP1194450A1 (fr) 2002-04-10
HUP0202389A3 (en) 2003-12-29
JP2003505400A (ja) 2003-02-12
FR2796282A1 (fr) 2001-01-19
WO2001005835A1 (fr) 2001-01-25
DE60015127T2 (de) 2005-10-13
ES2231233T3 (es) 2005-05-16
HU228430B1 (en) 2013-03-28
PL352461A1 (en) 2003-08-25
JP4841775B2 (ja) 2011-12-21
KR20090007803A (ko) 2009-01-20
DE60015127D1 (de) 2004-11-25
AU6576400A (en) 2001-02-05
ATE280182T1 (de) 2004-11-15
PT1194450E (pt) 2005-03-31
AR024770A1 (es) 2002-10-23
BR0012500A (pt) 2002-04-02
KR20080012405A (ko) 2008-02-11
CA2378802A1 (en) 2001-01-25
HUP0202389A2 (hu) 2002-12-28
CA2378802C (en) 2012-01-24
FR2796282B1 (fr) 2001-10-26

Similar Documents

Publication Publication Date Title
NL1014872A1 (nl) Aandrijving.
BR0014930B1 (pt) cÂnula.
TR200000520A3 (tr) 4-Fenil-piridin türevleri.
DE60032842D1 (de) Tintenstrahldrucker
DE60025890D1 (de) Verbesserter Druckkopf
TR200000471A3 (tr) Daire-ve-dogru yörünge verileri kullanilarak verimli konik-isin olusturulmasi.
NL1015211A1 (nl) Aandrijving.
ITBO990171A0 (it) Macchina depallettizzatrice .
DE60014236D1 (de) Tintenstrahldrucker
DE60030604D1 (de) Tintenstrahldrucker
BR0012500B1 (pt) vacina inativa contra a calicivirose felina.
DE60034972D1 (de) Tintenstrahldrucker
IT1316059B1 (it) Depigmentanti cutanei.
IT1319526B1 (it) Macchina i.s.
ITRM20010017V0 (it) Aspiratore a succhietto.
IT1319528B1 (it) Macchina i.s.
IT1310733B1 (it) Macchina operatrice.
IT1318610B1 (it) Micomelanine a struttura polinaftoica.
DE59912578D1 (de) Turbomaschinenschaufel
FR2790466B1 (fr) Machine i.s.
ES1044367Y (es) Piñata mejorada.
FR2796281B1 (fr) Vaccin inactive contre la calicivirose feline
ES1044558Y (es) Sandalia perfeccionada.
IT1314233B1 (it) Vaccino per hiv.
SE9900774D0 (sv) Hålslag

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/03/2011, OBSERVADAS AS CONDICOES LEGAIS.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 22.03.2021